Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells
Sak, M; Zumbar, CT; King, PD; Li, XH; Mifsud, CS; Usubalieva, A; Anderson, CD; Chesnick, HM; McElroy, JP; Chakravarti, A; Burton, EC; Lehman, NL
Lehman, NL (reprint author), Univ Louisville, Dept Pathol & Lab Med, Louisville, KY 40202 USA.; Lehman, NL (reprint author), Univ Louisville, Dept Biochem & Mol Genet, Louisville, KY 40202 USA.; Lehman, NL (reprint author), Univ Louisville, Brown Canc Ctr
JOURNAL OF NEURO-ONCOLOGY, 2019; 143 (2): 231